Comparision of two drugs , Madanphala and Jeemutaka in the patients of Amlapitta (non-ulcer Dyspepsia) by Vamana(therapeutic emesis)

A COMPARATIVE STUDY OF VAMANA KARMA BETWEEN MADANPHALA AND JEEMUTAKA IN AMLAPITTA

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009797

Enrollment

Registered

2017-09-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from Amlapitta

Interventions

Intervention1: Jeemutaka: Group B - Vamana with Jeemutaka decoction Control Intervention1: Madanphala: Group A - vamana with Madanphala decoction

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having symptoms like Chardi, tiktaamla udgara, avipaka, utklesha, kantha daha, hrud daha 2. patients between age group 18-60yrs 3. patients of either sexes

Exclusion criteria

Exclusion criteria: 1.Patients with complications like cardiac problems, emphysema, carcinoma etc. 2. pregnant women and lactating mothers 3. patients above 60yrs and below 18yrs.

Design outcomes

Primary

Measure	Time frame
The effects of the Madanphala and Jeemutaka as Vamakadravya in Amlapitta. Timepoint: Same Day (0 day)	—

Secondary

Measure	Time frame
reduction in the signs and symptoms of AmlapittaTimepoint: on 15th day and 30th day from the date of Vamana	—

Countries

India

Contacts

Public ContactDr Santosh E Chavan

Bharati Vidyapeeth Deemed University College of Ayurved Dhankawdi Pune-43

rajnisharma.oct@gmail.com7507373663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026